Navigation Links
Arterial disease awareness cuts heart attacks and leg amputations, claim UK vascular surgeons
Date:3/6/2010

Circulation Foundation believe we could reduce number of patients undergoing leg amputation and detect heart disease earlier if diagnosis and treatment of Peripheral Arterial Disease (a hardening or blockage of arteries in the legs) were given higher priority by the NHS and there was better public awareness. Each year 5,000 leg amputations are carried out in England and Wales, the majority of which are caused by PAD, but there are currently no national clinical standards for doctors to follow and public awareness is low.

(PRWeb UK) March 6, 2010 -- UK could reduce number of patients undergoing leg amputation and detect heart disease earlier if diagnosis and treatment of Peripheral Arterial Disease (a hardening or blockage of arteries in the legs) were given higher priority by the NHS and there was better public awareness say the Circulation Foundation. Each year 5,000 leg amputations are carried out in England and Wales, the majority of which are caused by PAD, but there are currently no national clinical standards for doctors to follow and public awareness is low.

Speaking ahead of Saving Legs - a major vascular surgery meeting to coincide with Vascular Disease Awareness Week - Professor Cliff Shearman, President of the Vascular Society said: “We need to start detecting PAD earlier. Recognising and treating PAD in its early stages not only helps to save people’s legs, it also reduces the number of people at risk of heart attacks and stroke as PAD is often a marker of cardiovascular problems.”

PAD is common in adults over 55 with up to 30 per cent of the age group showing signs of the vascular disease but is little known to the public. Four per cent of adults over 55 have symptoms of ‘claudication’, or pain in the muscles of the leg, which restricts walking. If left untreated PAD can result in amputation of the leg but currently over 50 per cent of people who loose their legs from PAD have had no previous treatment to improve their circulation, and there are large variations in the amputation rates across the country.

Research charity the Circulation Foundation says that PAD can be simply detected, but many patients remain undiagnosed. From 8-13 March, the charity is running awareness events across the country explaining the symptoms of PAD, and is publishing new patient information that explains how healthy lifestyle choices can help reduce the build up and hardening of the arteries, the main cause of the disease.

Mr Jonothan Earnshaw, Consultant Vascular Surgeon, Honorary Secretary of the Vascular Society said: “Everyone over the age of 40 should be ‘vascular aware’ as hardening of the arteries can cause a variety of serious health problems. In some cases early signs such as mild pain in the legs can progress to gangrene or amputation if PAD is left untreated, particularly for smokers and people with diabetes. The earlier the hardening of the arteries is detected, the more that can be done to prevent the complications of PAD and related risk of life- threatening episodes such as heart attacks and strokes.”

Louise Allen, Vascular Nurse Specialist and co-author of new Circulation Foundation patient handbook ‘Are your legs killing you?’ comments: “Many people are simply unaware of the early symptoms of peripheral arterial disease and that they can help to guard against or slow down the progression of the disease by making healthy lifestyle choices, ultimately reducing the risk of amputating a limb.”

Ann Keen, Parliamentary Under Secretary of State for Health, said "Stopping smoking is the single biggest prevention measure for vascular disease, that's one of the reasons why we're investing in initiatives such as the NHS Stop Smoking Quit Kit, which has been designed by experts and smokers and a wave of TV advertising which motivates smokers to quit for their children.

"There are prevention strategies in place to tackle vascular disease, particularly those which stem from the Coronary Heart Disease, Diabetes National Service Frameworks and the new NHS Health Check programme. Primary Care Trusts began phased implementation of the NHS Health Check programme from April 2009. This is a national preventative programme that will assess people's risk of heart disease, stroke, kidney disease and diabetes and will support people to reduce or manage that risk through individually tailored advice. However, we recognise that it is extremely important that existing disease is picked up by the NHS and the vital role GPs can play in this. Having knowledge about peripheral arterial disease is a fundamental aspect of a GP’s caseload, it is included within the current curriculum for GP specialty training and I welcome this opportunity to raise its profile."

Vascular Disease Awareness Week (8th – 12th March) is run by the Circulation Foundation, the UK’s only national charity dedicated to raising money for pioneering research into the causes, prevention and treatment of vascular disease.

Details about screening and fundraising events supporting Vascular Disease Awareness Week can be found at www.circulationfoundation.org.uk, which also provides information, support and advice on vascular disease.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3691234.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
2. Riverside First to Offer New Treatment for Peripheral Arterial Disease
3. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
4. American College of Physicians publishes "Peripheral Arterial Disease"
5. Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
6. Arterial vascular disease underdiagnosed, undertreated in older US women
7. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble
8. Asian women at risk for arterial defect
9. Safe at Any Age: Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures
10. Methamphetamine Use Associated With Pulmonary Arterial Hypertension in Patients With Previously Unknown Risk Factors
11. Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... Dr. James Maisel will present on ... Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. The ... Group of New York , is a Board Certified ophthalmologist who completed his ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... multitude of activities from daily practices, arts & crafts, discussions, and games all ... East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, collegiate sport yoga ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... ... ... A health conscious snack that doesn't sacrifice taste? It's possible! In one ... buzz in the protein product community by offering an alternative to the traditional bar ... with 11 grams of protein and made from a healthy blend of high quality ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: